CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7 enrolled
Drug / intervention
IOWA Approach Cardiac Ablation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03700372
NCT03700372N/ACompleted
CompareCT.gov

IMPACT: A Safety and Feasibility Study of the IOWA Approach Cardiac Ablation System

Boston Scientific Corporation·interventional·Posted Oct 9, 2018·Updated Oct 14, 2021

In Brief

A clinical study evaluating IOWA Approach Cardiac Ablation System for Paroxysmal Atrial Fibrillation. Completed, enrolled 7 participants across 1 site.

Detailed Summary

IMPACT is a prospective, single-arm, multi-center, safety and feasibility study evaluating the IOWA Approach Cardiac Ablation System (FARAPULSE, Inc.) for the treatment of paroxysmal atrial fibrillation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParoxysmal Atrial Fibrillation
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 9, 2018
Enrollment StartDec 13, 2017
Primary CompletionApr 9, 2019
Study CompletionMar 3, 2021
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 7.7 years ago

Interventions

IOWA Approach Cardiac Ablation Systemdevice

Epicardial ablation using the IOWA Approach Cardiac Ablation System